115 related articles for article (PubMed ID: 3561445)
1. Demyelination in vivo by Guillain-Barré syndrome and other human serum.
Brown MJ; Rosen JL; Lisak RP
Muscle Nerve; 1987; 10(3):263-71. PubMed ID: 3561445
[TBL] [Abstract][Full Text] [Related]
2. Demyelination induced by serum from patients with Guillain-Barré syndrome.
Harrison BM; Hansen LA; Pollard JD; McLeod JG
Ann Neurol; 1984 Feb; 15(2):163-70. PubMed ID: 6703656
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of sera from Guillain-Barré subgroups: an electrophysiological and histological study on rat nerves.
Oomes PG; van der Meché FG; Markus-Silvis L; Meulstee J; Kleyweg RP
Muscle Nerve; 1991 Oct; 14(10):1013-20. PubMed ID: 1658645
[TBL] [Abstract][Full Text] [Related]
4. [Electrophysiological and morphological effects of the injection of Guillain-Barré sera in the sciatic nerve of the rat (author's transl)].
Sumner A; Said G; Idy I; Metral S
Rev Neurol (Paris); 1982; 138(1):17-24. PubMed ID: 7100734
[TBL] [Abstract][Full Text] [Related]
5. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome.
Saida T; Saida K; Lisak RP; Brown MJ; Silberberg DH; Asbury AK
Ann Neurol; 1982 Jan; 11(1):69-75. PubMed ID: 7059130
[TBL] [Abstract][Full Text] [Related]
6. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
Sawant-Mane S; Clark MB; Koski CL
Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
[TBL] [Abstract][Full Text] [Related]
7. [Effector mechanisms of PNS demyelination in Gal-C induced-EAN].
Saida K
Rinsho Shinkeigaku; 1990 Dec; 30(12):1361-3. PubMed ID: 2129197
[TBL] [Abstract][Full Text] [Related]
8. Absence of antimyelin antibodies and serum demyelinating factors in most patients with chronic inflammatory demyelinating polyradiculoneuropathy.
McCombe PA; Pollard JD; McLeod JG
Clin Exp Neurol; 1988; 25():53-60. PubMed ID: 3267485
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
Buchwald B; Toyka KV; Zielasek J; Weishaupt A; Schweiger S; Dudel J
Ann Neurol; 1998 Dec; 44(6):913-22. PubMed ID: 9851436
[TBL] [Abstract][Full Text] [Related]
10. Humoral mechanisms in immune neuropathies.
Koski CL
Neurol Clin; 1992 Aug; 10(3):629-49. PubMed ID: 1501599
[TBL] [Abstract][Full Text] [Related]
11. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
[TBL] [Abstract][Full Text] [Related]
12. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
Nomura K
Rinsho Shinkeigaku; 1996 Dec; 36(12):1367-9. PubMed ID: 9128414
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome.
Koski CL; Gratz E; Sutherland J; Mayer RF
Ann Neurol; 1986 Jun; 19(6):573-7. PubMed ID: 3729311
[TBL] [Abstract][Full Text] [Related]
14. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
Sharief MK; McLean B; Thompson EJ
Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
[TBL] [Abstract][Full Text] [Related]
17. In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study.
Saida K; Saida T; Brown MJ; Silberberg DH
Am J Pathol; 1979 Apr; 95(1):99-116. PubMed ID: 434114
[TBL] [Abstract][Full Text] [Related]
18. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome.
Koski CL
Ann Neurol; 1990; 27 Suppl():S44-7. PubMed ID: 2194426
[TBL] [Abstract][Full Text] [Related]
19. Abnormal serum factors in Guillain-Barré syndrome.
Lisak RP; Brown MJ; Summer AJ
Ital J Neurol Sci; 1983 Sep; 4(3):265-72. PubMed ID: 6358121
[TBL] [Abstract][Full Text] [Related]
20. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
Koski CL; Chou DK; Jungalwala FB
J Clin Invest; 1989 Jul; 84(1):280-7. PubMed ID: 2738153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
